| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/20/2004 | CA2078235C Idiotypic vaccination against b cell lymphoma |
| 01/15/2004 | WO2004005509A1 Method of examining allergic disaese and drug for treating the same |
| 01/15/2004 | WO2004005493A1 Animal protein free media for cultivation of cells |
| 01/15/2004 | WO2004005476A2 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | WO2004005423A1 Allergen inactivator |
| 01/15/2004 | WO2004005350A2 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 01/15/2004 | WO2004005334A2 Nucleic acid molecule encoding an allergen preprotein of a mite of genus dermatophagoides or euroglyphus and use thereof for protecting said allergen in plants |
| 01/15/2004 | WO2004005313A2 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 01/15/2004 | WO2004005310A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/15/2004 | WO2004005309A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 01/15/2004 | WO2004005296A1 Novel derivative of flavone c-glycoside and composition containing the same |
| 01/15/2004 | WO2004005293A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 01/15/2004 | WO2004005276A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | WO2004005258A1 Di-aryl-substituted-ethane pyridone pde4 inhibitors |
| 01/15/2004 | WO2004005243A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 01/15/2004 | WO2004005229A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | WO2004004778A1 Use of cetp inhibitors and optionally hmg coa reductable inhibitors and/or antihypertensive agents |
| 01/15/2004 | WO2004004771A1 Immunopotentiating compositions |
| 01/15/2004 | WO2004004758A1 Method to enhance an immune response of nucleic acid vaccination |
| 01/15/2004 | WO2004004753A1 Peptide having an immunoregulatory property and the composition of said peptide |
| 01/15/2004 | WO2004004750A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 01/15/2004 | WO2004004743A1 Immunostimulation by chemically modified rna |
| 01/15/2004 | WO2004004735A1 Remedy comprising combination of levocabastine with pemirolast |
| 01/15/2004 | WO2004004725A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 01/15/2004 | WO2004004713A1 Fredericamycin derivatives as medicaments for treating tumours |
| 01/15/2004 | WO2004004703A1 m-PHENYLENEDIAMINE DERIVATIVE |
| 01/15/2004 | WO2004004698A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | WO2004004633A2 Use of tnfalpha antibodies and another drug |
| 01/15/2004 | WO2004004483A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/15/2004 | WO2003094950A8 A method of inhibiting the emigration of cells from the intravascular compartment into tissues |
| 01/15/2004 | WO2003094831A3 Novel diazabicyclic biaryl derivatives |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | WO2003089434A3 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF |
| 01/15/2004 | WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 01/15/2004 | WO2003080118A3 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 01/15/2004 | WO2003073827A3 Methods of modulating dendritic cells using adjuvants |
| 01/15/2004 | WO2003070905A3 Electroporation methods for introducing bioactive agents into cells |
| 01/15/2004 | WO2003061587A3 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 01/15/2004 | WO2003060072A3 Recombinant polypeptides |
| 01/15/2004 | WO2003054008A3 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 01/15/2004 | WO2003049682A3 Composition and method for treating chronic allograft rejection |
| 01/15/2004 | WO2003019146A3 High throughput screening assays using fatty acid synthetic enzymes |
| 01/15/2004 | WO2002096866A3 Thiolalkyl benzoic acid derivatives |
| 01/15/2004 | WO2002080966A8 Method for producing a vaccine containing autologous antibodies |
| 01/15/2004 | WO2002078637A9 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040010147 Cyclic amine compounds and pharmaceutical composition containing the same |
| 01/15/2004 | US20040010141 Antiinflammatory agents; anticancer agents; rheumatic disorders; cardiovascular disorders |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010125 Human immunodeficiency viral glycoprotein (HIV) for diagnosis, prevention and treatment of viral infection; genetic vaccines |
| 01/15/2004 | US20040010124 CD16A binding proteins and use for the treatment of immune disorders |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010027 Tumor angiogenesis and metastasis inhibition. |
| 01/15/2004 | US20040010020 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010008 Piperidine derivatives useful as CCR5 antagonists |
| 01/15/2004 | US20040010007 Also thio, sulfoxy and sulfonyl derivatives; imidazotetrazolopyrimidines and intermediates |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040009998 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 01/15/2004 | US20040009996 4-(1,2- or 2,1-benzoxazol-5-yl)-2-aminopyrimidines |
| 01/15/2004 | US20040009995 Treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade |
| 01/15/2004 | US20040009994 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 01/15/2004 | US20040009983 Azaindoles |
| 01/15/2004 | US20040009981 Oxazole, thiazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives of pyrimidines, 1,2,4- and 1,3,5-triazines |
| 01/15/2004 | US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles |
| 01/15/2004 | US20040009968 Indazole compounds useful as protein kinase inhibitors |
| 01/15/2004 | US20040009967 May contain further anticancer or immunosuppressive agents |
| 01/15/2004 | US20040009939 Methods of enhancing immune induction involving MDA-7 |
| 01/15/2004 | US20040009913 Detecting, identifying and screening for srf signal transduction pathway elements for diagnosis |
| 01/15/2004 | US20040009906 Induction of antigen specific immunologic tolerance |
| 01/15/2004 | US20040009905 Templates consist of cyclized peptides containing at least two residues in said cyclized peptide are joined by a naphthyl ring; and having bonded to it a linear peptide |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009895 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 01/15/2004 | US20040009195 Modified sialic acid vaccines |
| 01/15/2004 | US20040009191 Inactivated virulence genes |
| 01/15/2004 | US20040009185 Enhancing the immune response to an antigen by presensitzing with an inducing agent prior to immunizing with the agent and the antigen |
| 01/15/2004 | US20040009184 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 01/15/2004 | US20040009174 Reducing inflammation in smooth muscle tissue in a subject by administering to subject an effective amount of an agent which inhibits OX40 ligand binding to OX40; treatment of asthma |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009125 First series of intranasal administration of E-selectin over period of two weeks, followed by a booster administration of E-selectin after at least two weeks from the first administration of E-selectin to minimize brain tissue damage |
| 01/15/2004 | DE10226326A1 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene 9-alpha-substiuierte estratrienes as selective estrogens effective |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2492033A1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | CA2492010A1 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | CA2491992A1 Animal protein free media for cultivation of cells |
| 01/15/2004 | CA2491464A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | CA2490983A1 Immunostimulation by chemically modified rna |
| 01/15/2004 | CA2490952A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/15/2004 | CA2490714A1 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 01/15/2004 | CA2490708A1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 01/15/2004 | CA2490097A1 Di-aryl-substituted-ethane pyridone pde4 inhibitors |
| 01/15/2004 | CA2489402A1 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/15/2004 | CA2489398A1 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 01/15/2004 | CA2488736A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 01/14/2004 | EP1380593A1 Soluble rage protein |